Zhang’s group at Duke is studying the half of the human genome that is made up of long, repetitive sequences of DNA called transposons, or “jumping genes.” They’re given that nickname because of their habit of jumping around in the genome, making changes and enabling evolution.

Study of 107 older adults finds that non-white New York and North Carolina residents with mild cognitive impairment reside in places with more environmental injustices than their white peers.

Congratulations to the 433 students from the Duke University School of Medicine who graduated on Sunday, May 12, 2024, marking the successful culmination of their hard work and dedication. Stu

The first Black woman to graduate from the Duke School of Medicine in 1972, Jean Spaulding went on to help lead Duke Health as an administrator, making primary health care accessible to low-wealth residents across Durham and beyond.

A team of Duke researchers describe a synthetic molecule that mimics the effects of compounds in the saliva of blood-sucking critters that can also be swiftly reversed, enabling clotting to resume when needed after treatment.

Researchers at Duke University School of Medicine have secured a contract from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) for up to $6 million

Discovery paves the way for more effective cancer treatments that benefit a larger group of patients.

Medical students at Duke University School of Medicine have selected selected Jamie Fox, MD; Erica Odukoya, MD; and Jenny Van Kirk, MD; for the 2024 annual Golden Apple Awards.   

Duke Health leaders have selected seven high-potential innovation projects to be implemented as part of the Duke Institute for Health Innovation (DIHI)’s annual call for project ideas.

Duke Cancer Institute is rewriting the narrative for patients with bladder and urothelial cancer by pursuing innovative combination therapy.